1. Home
  2. JYNT vs CBUS Comparison

JYNT vs CBUS Comparison

Compare JYNT & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Joint Corp.

JYNT

The Joint Corp.

HOLD

Current Price

$8.56

Market Cap

120.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo Cibus Inc.

CBUS

Cibus Inc.

HOLD

Current Price

$1.96

Market Cap

208.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
JYNT
CBUS
Founded
2010
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Agricultural Chemicals
Sector
Miscellaneous
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
120.7M
208.7M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
JYNT
CBUS
Price
$8.56
$1.96
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$17.00
$9.00
AVG Volume (30 Days)
65.6K
647.6K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
133.93
74.33
EPS
0.19
N/A
Revenue
$117,696,356.00
$3,639,000.00
Revenue This Year
$12.23
$126.00
Revenue Next Year
N/A
$110.01
P/E Ratio
$45.16
N/A
Revenue Growth
15.49
N/A
52 Week Low
$7.50
$1.09
52 Week High
$13.47
$4.19

Technical Indicators

Market Signals
Indicator
JYNT
CBUS
Relative Strength Index (RSI) 48.64 36.26
Support Level $8.46 $1.31
Resistance Level $8.67 $2.48
Average True Range (ATR) 0.28 0.32
MACD 0.06 -0.16
Stochastic Oscillator 66.67 13.62

Price Performance

Historical Comparison
JYNT
CBUS

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: